4 news items
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
EVOK
16 May 24
side effects relating to GIMOTI that could result in recalls or product liability claims; Evoke's ability to maintain intellectual property
Evoke Pharma Reports First Quarter 2024 Financial Results
EVOK
14 May 24
; inadequate efficacy or unexpected adverse side effects relating to GIMOTI that could result in recalls or product liability claims; Evoke's ability
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
EVOK
17 Apr 24
in recalls or product liability claims; Evoke's ability to maintain intellectual property protection for GIMOTI; and other risks and uncertainties detailed
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer
EVOK
21 Mar 24
side effects relating to GIMOTI that could result in recalls or product liability claims; Evoke's ability to maintain intellectual property protection
- Prev
- 1
- Next